Skip to main content
ASRAFALL24 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Track: Main Meeting

RC-03 - Rethinking CRPS

Thursday, November 21, 2024
1:30 PM - 3:30 PM PT
Location: Julius 24
CE: 2

Disclosure(s):
Anuj Bhatia, MD: No financial relationships to disclose

Learning Objectives:

  • Understand the recent advances in the research on pathophysiology of CRPS
  • Discuss the role of various theraeutic strategies for CRPS
  • List the current diagnostic criteria for CRPS

Presentations:

  • 1:30 PM - 1:35 PM PT
    MORBIDITY AND MORTALITY FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY WITH SPINAL VS. GENERAL ANESTHESIA: A RETROSPECTIVE ANALYSIS - Mucharraz
  • 1:35 PM - 1:40 PM PT
    RANDOMIZED CONTROLLED TRIAL: LUMBAR MEDIAL BRANCH CRYONEUROLYSIS VERSUS RADIOFREQUENCY ABLATION FOR CHRONIC LOW BACK PAIN - Cliff
  • 1:40 PM - 2:05 PM PT
    Pathophysiology of CRPS - Defining Treatment Targets

    Speaker: Christine Hunt, DO, MS (she/her/hers) – Mayo Clinic

  • 2:05 PM - 2:30 PM PT
    Rethinking Pharmacology in CRPS: From Buprenorphine to Biologics

    Speaker: Steven P. Cohen, MD (he/him/his) – Northwestern, Walter Reed

  • 2:30 PM - 2:55 PM PT
    Physical Therapy Recommendations: Initiation, Dose and Periodization

    Speaker: James Braxton, OT, CHT (he/him/his) – Mayo Clinic

    Speaker: Brian Mecca, PT, DPT, OCS, FAAOMPT (he/him/his) – Mayo Clinic

  • 2:55 PM - 3:20 PM PT
    Novel Interventional Treatments in CRPS

    Speaker: Magdalena Anitescu, MD, PhD, FASA (she/her/hers) – University of Chicago

  • 3:20 PM - 3:30 PM PT
    Panel Discussion and Open Forum